Mutations in fibroblast growth factor receptor-2 in apert syndrome promote fetal human calvaria cell differentiation and mesenchyme condensation.

被引：0
|
作者：
Lomri, A
Lemonnier, J
dePollak, C
Hott, M
deParseval, N
Lajeunie, E
Munnich, A
Renier, D
Marie, PJ
机构：
[1] LARIBOISIERE HOSP,INSERM U349,PARIS,FRANCE
[2] HOP ENFANTS MALAD,DEPT PEDIAT NEUROSURG,PARIS,FRANCE
[3] INSERM U393,PARIS,FRANCE
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1997年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：91 / 91
页数：1
相关论文
共 50 条
  • [21] Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma
    Wakulich, C
    Jackson-Boeters, L
    Daley, TD
    Wysocki, GP
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2002, 93 (05): : 573 - 579
  • [22] Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes
    Yu, K
    Ornitz, DM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (07) : 3641 - 3643
  • [23] The Apert S252W mutation in fibroblast growth factor receptor-2 increases apoptosis through PKC, IL-1 and downstream activation of caspases-8 and-3 in human calvaria osteoblasts.
    Lemonnier, J
    Haÿ, E
    Delannoy, P
    Lomri, A
    Fromigué, O
    Marie, PJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S212 - S212
  • [24] Fibroblast growth factor receptor 2 with Apert mutation (S252W) increase osteoblast differentiation and mineralization.
    Tanimoto, Y
    Yokozeki, M
    Hiura, K
    Moriyama, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S194 - S194
  • [25] Antitumor Activity of a Recombinant Soluble Ectodomain of Mutant Human Fibroblast Growth Factor Receptor-2 IIIc
    Wang, Ju
    Liu, Xue-ting
    Huang, Hui
    Xiao, Gang
    Zhou, Zhi-you
    Chen, Yang
    Yu, Zhi-hong
    He, Shui-lian
    Chen, An-an
    Wang, Ding-ding
    He, Ying
    Zhang, Zhi-cheng
    Hong, An
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (09) : 1656 - 1666
  • [26] Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome
    Przylepa, KA
    Paznekas, W
    Zhang, MH
    Golabi, M
    Bias, W
    Bamshad, MJ
    Carey, JC
    Hall, BD
    Stevenson, R
    Orlow, SJ
    Cohen, MM
    Jabs, EW
    NATURE GENETICS, 1996, 13 (04) : 492 - 494
  • [27] Hearing, Speech, Language, and Communicative Participation in Patients With Apert Syndrome: Analysis of Correlation With Fibroblast Growth Factor Receptor 2 Mutation
    Kilcoyne, Sarah
    Luscombe, Carrie
    Scully, Paula
    Overton, Sarah
    Brockbank, Sally
    Swan, Marc C.
    Johnson, David
    Wall, Steven
    Wilkie, Andrew O. M.
    JOURNAL OF CRANIOFACIAL SURGERY, 2022, 33 (01) : 243 - 250
  • [28] Fibroblast growth factor receptor-2 activation is independent of bFGF concentration in the human endothelial cell response to sustained hydrostatic pressure.
    Schwartz, EA
    Bizios, R
    Gerritsen, ME
    FASEB JOURNAL, 1999, 13 (05): : A1020 - A1020
  • [29] The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation
    Lemonnier, J
    Delannoy, P
    Hott, M
    Lomri, A
    Modrowski, D
    Marie, PJ
    EXPERIMENTAL CELL RESEARCH, 2000, 256 (01) : 158 - 167
  • [30] Detection of the S252W mutation in fibroblast growth factor receptor 2 (FGFR2) in fetal DNA from maternal plasma in a pregnancy affected by Apert syndrome
    Au, Patrick K. C.
    Kwok, Yvonne K. Y.
    Leung, K. Y.
    Tang, Linda Y. F.
    Tang, Mary H. Y.
    Lau, Elizabeth T.
    PRENATAL DIAGNOSIS, 2011, 31 (02) : 218 - 220
12345